Fidelity Investments’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $626M | Buy |
55,509,281
+3,842,770
| +7% | +$43.3M | 0.04% | 408 |
|
|
2025
Q1 | $521M | Buy |
51,666,511
+2,364,928
| +5% | +$23.9M | 0.03% | 434 |
|
|
2024
Q4 | $583M | Buy |
49,301,583
+156,527
| +0.3% | +$1.85M | 0.03% | 420 |
|
|
2024
Q3 | $567M | Buy |
49,145,056
+2,593,910
| +6% | +$29.9M | 0.03% | 432 |
|
|
2024
Q2 | $492M | Buy |
46,551,146
+11,210,583
| +32% | +$118M | 0.03% | 451 |
|
|
2024
Q1 | $372M | Sell |
35,340,563
-1,635,685
| -4% | -$17.2M | 0.03% | 552 |
|
|
2023
Q4 | $415M | Sell |
36,976,248
-1,934,377
| -5% | -$21.7M | 0.03% | 470 |
|
|
2023
Q3 | $454M | Buy |
38,910,625
+2,913,491
| +8% | +$34M | 0.04% | 420 |
|
|
2023
Q2 | $363M | Buy |
35,997,134
+5,234,850
| +17% | +$52.8M | 0.03% | 511 |
|
|
2023
Q1 | $227M | Buy |
30,762,284
+390,794
| +1% | +$2.88M | 0.02% | 662 |
|
|
2022
Q4 | $243M | Buy |
30,371,490
+26,196,460
| +627% | +$209M | 0.02% | 619 |
|
|
2022
Q3 | $13.4M | Buy |
4,175,030
+1,675,030
| +67% | +$5.39M | ﹤0.01% | 1772 |
|
|
2022
Q2 | $10.2M | Hold |
2,500,000
| – | – | ﹤0.01% | 1957 |
|
|
2022
Q1 | $12.4M | Hold |
2,500,000
| – | – | ﹤0.01% | 2028 |
|
|
2021
Q4 | $25.2M | Buy |
+2,500,000
| New | +$25.2M | ﹤0.01% | 1714 |
|